Gene and Cell Therapy – Products

ProteoNic Biosciences, announced a partnership with Ginkgo Bioworks (NYSE: DNA). This strategic alliance will grant Ginkgo Bioworks’ customers access to ProteoNic's state of the art vector technology in the field of protein production.

New data builds on earlier findings from a post-hoc Phase 2 analysis that helped reposition BioSenic’s oral arsenic trioxide (OATO) program for pivotal trials.

Ensure the highest standard of patient safety with the Microsart® ATMP Sterile Release Kit, the definitive solution for rapid detection of bacterial and fungal contamination in cell therapy products. Our kit combines the precision of Microsart® ATMP Bacteria and Microsart® ATMP Fungi tests, utilizing the trusted real-time PCR method to deliver accurate results within just 3 hours.

With the Microsart® ATMP Sterile Release Kit, you can confidently release contamination-free cell therapy products, significantly reducing the reliance on prophylactic antibiotics and safeguarding patient health. Our unique kit stands alone in the market, offering an unmatched level of testing that no other product can provide.

But how do you purify small volumes for preclinical and clinical studies without losing too much to processing or leaving capacity unused?

Rapid, sensitive, and validated detection of viral replication genes using droplet digital™ PCR during cell and gene therapy production.

N4 Pharma PLC (AIM: N4P), recently acquired a controlling interest in Nanogenics Limited.

This article examines recent advancements in cell therapy research, from promising lab findings poised for clinical translation to enhancements in development, testing, and manufacturing processes.

Cell therapies, from regenerative medicine to immunotherapy, are transforming the medical landscape with 75 already approved globally and over 2,000 in development.

New off-the-shelf system reduces the cost and risk of lentiviral (LV) production for cell and gene therapy developers. Single-plasmid transfection minimizes GMP plasmid costs and supply chain risk.

CELLBANKER® freezing media from AMSBIO is now available in customizable formats, seamlessly integrating into cell manufacturing processes with personalized formulations, volumes, and packaging.